Cargando…
Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
Chronic disease caused by infections, cancer or autoimmunity can result in profound immune suppression. Immunoregulatory networks are established to prevent tissue damage caused by inflammation. Although these immune checkpoints preserve tissue function, they allow pathogens and tumors to persist, a...
Autores principales: | Faleiro, Rebecca J., Kumar, Rajiv, Bunn, Patrick T., Singh, Neetu, Chauhan, Shashi Bhushan, Sheel, Meru, Amante, Fiona H., Montes de Oca, Marcela, Edwards, Chelsea L., Ng, Susanna S., Best, Shannon E., Haque, Ashraful, Beattie, Lynette, Hafner, Louise M., Sacks, David, Nylen, Susanne, Sundar, Shyam, Engwerda, Christian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752322/ https://www.ncbi.nlm.nih.gov/pubmed/26872334 http://dx.doi.org/10.1371/journal.pntd.0004415 |
Ejemplares similares
-
Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis
por: Bunn, Patrick T., et al.
Publicado: (2017) -
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2020) -
Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology
por: Montes de Oca, Marcela, et al.
Publicado: (2016) -
Correction: Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology
por: Montes de Oca, Marcela, et al.
Publicado: (2016) -
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection
por: Montes de Oca, Marcela, et al.
Publicado: (2016)